Hubungan Lama Rawat Inap dengan Usia dan Komorbiditas Pasien COVID-19 di Semen Padang Hospital dari Maret hingga Juli 2020

Akbar Shiddiq, Fauzar Fauzar, Roza Kurniati, Alexander Kam

Abstract


Abstrak

 Pendahuluan: Penyakit Coronavirus 2019 (COVID-19) merupakan salah satu penyakit yang sedang menjadi pandemi. Berdasarkan data World Health Organization (WHO) hingga Juli 2020, ditemukan angka kejadian mencapai lebih dari 17 juta di dunia. Sebagian besar orang sekitar 80% sembuh tanpa memerlukan perawatan khusus, tetapi beberapa orang yang memiliki penyakit penyerta dapat menyebabkan gejala yang berat. Sekitar 1 dari setiap 5 orang yang terinfeksi COVID-19 membutuhkan perawatan di rumah sakit dan lama perawatan yang berbeda. Tujuan: Penelitian ini bertujuan untuk mengetahui distribusi usia dan komorbiditas, hubungan lama rawat inap dengan usia dan komorbiditas pasien COVID-19 di Semen Padang Hospital. Metode: Penelitian ini adalah deskriptif korelatif dengan desain cross sectional. Dari pengumpulan data didapatkan 60 pasien COVID-19 dari bulan Maret hingga Juni 2020. Hasil: Didapatkan 6 pasien pada kelompok usia 0-18 tahun (10%), 38 pasien pada kelompok usia 19-59 tahun (63,3 %), dan 16 pasien pada kelompok usia ≥ 60 tahun (26,7 %). Berdasarkan analisis bivariat diperoleh hasil p = 0,599 (p > 0,05). Terdapat 17 pasien dengan komorbiditas (28,3 %) dan 43 pasien tanpa komorbiditas (71,7 %). Hasil yang diperoleh p = 0,513 (p > 0,05). Simpulan: Didapatkan bahwa tidak ada hubungan lama rawat inap dengan usia dan komorbiditas. Distribusi prevalensi COVID-19 terbanyak didapatkan pada pasien tanpa komorbiditas dan pada kelompok dewasa usia 19-59 tahun.

Katakunci — COVID-19, lama rawat inap, usia, komorbiditas

 

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) is a disease that is currently becoming a pandemic. Based on data from the World Health Organization (WHO) until July 2020, it was found that the incidence reached more than 17 million in the world. Most people about 80% recover without needing special treatment, but some people who have co-morbidities can cause severe symptoms. About 1 in every 5 people infected with COVID-19 requires hospitalization and a different length of treatment. Aims: This study aims to determine the distribution of age and comorbidities, the relationship between length of stay and age and comorbidities of COVID-19 patients at Semen Padang Hospital. Methods: This research is descriptive correlative with cross sectional design. From data collection, there were 60 COVID-19 patients from March to June 2020. Results: There were 6 patients in the 0-18 years age group (10%), 38 patients in the 19-59 year age group (63.3 %), and 16 patients in the age group 60 years (26.7 %). Based on the bivariate analysis, the results were p = 0.599 (p > 0.05). There were 17 patients with comorbidities (28.3%) and 43 patients without comorbidities (71.7%). The results obtained were p = 0.513 (p > 0.05). Conclusion: It was found that there was no relationship between length of hospitalization with age and comorbidities. The highest prevalence distribution of COVID-19 was found in patients without comorbidities and in the adult group aged 19-59 years.

Keywords— COVID 19, length of stay, age, comorbidity

 


Full Text:

PDF

References


Susilo A, Rumende CM, Pitoyo CW, Santoso WD, Yulianti M, Herikurniawan H, et al. Coronavirus Disease 2019: review of current literatures. Jurnal Penyakit Dalam Indonesia. 2020;7(1):45-67.

Rosenbaum L. Facing COVID-19 in Italy - Ethics, logistics, and therapeutics on the epidemic’s front line. N Engl J Med. 2020; 382(20):1873–5.

Qiu H, Tong Z, Ma P, Hu M, Peng Z, Wu W, Du B. Intensive care during the coronavirus epidemic. Intensive Care Med. 2020; 46(4):576–8.

Morales RA, Ospina CJ, Ocampo GE, Pena VR, Rivera HY, Antezana EJ, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis. 2020:101623.

Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med. 2020:1–5.

Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239–42.

Bulut C, Kato Y. Epidemiology of COVID-19. Turkish Journal of Medical Sciences. 2020;50(SI-1):563-70.

Nikpouraghdam M, Farahani AJ, Alishiri G, Heydari S, Ebrahimnia M, Samadinia H, et al. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in Iran: A single center study. Journal of Clinical Virology. 2020.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395: 497-506.

Mei J. Coronavirus disease 2019 in children: current status. Journal of the chinese medical association. 2020; 83 (6): 527-33.

Snape MD, Viner RM. COVID-19 in children and young people. Science. 2020; 370: 286-8.

Dawood FS, Ricks P, Njie GJ, Dauhgerty M, Davis W, Fuller JA, et al. Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis. Lancet Infect Dis. 2020; 20: 1-9.

Alsofayan YM, Althunnayan SM, Khan AA, Hakawi AM, Assiri AM. Clinical characteristics of COVID-19 in Saudi Arabia: A National retrospective study. Journal of Infection and Public Health. 2020; 13: 920-5.

Liu Y, Mao B, Liang S, Yang JW, Lu H, Chai Y, et al. Associatian between ages and clinical characteristics and outcomes of coronavirus disease 2019. Eur Respir J. 2020.

Richardson S, Hirsch JS, Narasimhan M. Presenting characteristics, comorbidities, and outcome among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020; 323(20): 2052-59.

Rees EM, Nightingale ES, Jafari Y, Waterlow NR, Clifford S, Pearson CA, et al. COVID-19 length of hospital stay: a systematic review and data synthesis. Medrxiv. 2020:1-30.

Li B. The Association between symptom onset and length of hospital stay in 2019 novel coronavirus pneumonia cases without epidemiolgical trace. Journal of the National Medical Association. 2020: 1-2.

Zhao S, Lin Q, Ran J, Musa S, Yang G, Wang W, et al. Preeliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in china, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. Int J Infect Dis. 2020; 92: 214-7.

Wu C, Chen X, Cai Y. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in wuhan, china. 2020; 180 (7): 934-43.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in wuhan, china: a descriptive study. The Lancet. 2020; 395: 507-13.

Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its impact on patients with COVID-19. A Springer Nature Journal. 2020: 1-8.

Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et.al. Comorbidity and its impact on 1590 patients with COVID-19 in china: a nationwide analysis. Eur Respir J. 2020.




DOI: https://doi.org/10.33854/heme.v4i1.933

DOI (PDF): https://doi.org/10.33854/heme.v4i1.933.g339

Refbacks

  • There are currently no refbacks.


Creative Commons License   Health and Medical Journal This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.